New research suggests that patients who come off blockbuster slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass much more quickly than those who stop conventional diet and exercise regimens.
Published data in a leading medical journal shows that while obese people often shed substantial amounts of their body weight while using the jabs, the mass returns at an average rate of 0.8 kg per month upon discontinuation.
"People using these medications need to be informed of the danger of fast rebound weight gain when the medication is stopped," stated expert Dr. Susan Jebb.
This pace of regain suggests a return to starting mass in about 18 months.
Analyzing Therapies
The research, which reviewed dozens of studies involving thousands of participants, compared the outcomes of these new drugs with other pills.
The team note that people who lose weight through lifestyle changes alone typically see a more gradual weight regain—perhaps 100 grams monthly—post-intervention.
Explaining the Quick Regain
Nutrition scientists suggest the way of the injections accounts for the heightened regain.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Long-term administration of the hormone levels far above than normal may cause the body to generate a reduced amount of its own natural GLP-1, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement leads to hunger is uncontrolled, making excessive eating far more likely."
An Ongoing Disease?
Health authorities advise the jabs for people with weight-linked health risks, alongside prescribed lifestyle changes.
Many experts argue that, given the significant potential of weight regain, the therapy is often life-long.
This view is supported by drug manufacturers, who say that the findings "underscore the persistent character of excess weight," similar to managing conditions like high blood pressure.
Patient Testimonies
Users who have discontinued the jabs explain a powerful resurgence of hunger.
"I experienced something flipping and you become ravenous," described one woman.
This difficulty is worsened if patients have not adopted lasting dietary or behavioural modifications during therapy.
Growing Adoption
Recent estimates indicate that millions of people in the UK have tried these injections in the last 12 months, with demand being substantial.
- Adoption is higher among females than men.
- The middle-aged demographic shows the highest level of interest.
- Many obtain the drugs through private prescriptions rather than the NHS.
Ultimately, researchers caution that while the jabs are potent agents for weight loss, they are not a standalone cure and long-term success hinges on ongoing behavioural support.
